All HHS Contracts — July 01, 2026

Leidos won a cost-plus-fixed-fee delivery order from NIH for agile software development and design services supporting the eRA grants management system. The cost-plus structure reduces financial risk and provides stable margins, while options could expand the total value to $247.1 million.

The contract's cost-plus-fixed-fee structure, while reducing financial risk, still requires Leidos to manage scope and cost effectively to avoid margin compression. Any performance issues could affect option exercise.

This single award represents a significant portion of Leidos's civilian IT revenue. Over-reliance on a single agency (NIH) for growth in this segment could be a concentration risk if NIH budgets face future cuts.

If NIH exercises all options, the contract value could more than double to $247.1 million, providing a multi-year revenue stream for Leidos. This would signal deepening NIH trust and potential for follow-on work.

Leidos's win strengthens its position in the federal health IT market, a growing budget area. This could lead to additional awards from other HHS agencies (e.g., CDC, FDA) as digital modernization efforts expand.

The NIH's investment in modernizing its eRA grants management system via agile development reflects a broader civilian agency push to digitize and streamline core administrative functions. This contract is a direct example of the trend.

{"entity"=>"Leidos, Inc.", "reason"=>"This $113.5M contract is a material civilian IT win; option exercise will be a key catalyst for revenue growth.", "trigger"=>"NIH announcement of option exercise or follow-on task orders under this delivery order"}

{"entity"=>"National Institutes of Health", "reason"=>"As the awarding agency, NIH's budget trajectory and IT modernization priorities directly impact Leidos's contract value and future opportunities.", "trigger"=>"FY2027 NIH budget appropriations; release of new eRA-related RFPs"}